HMG-CoA reductase inhibitors: issues in assessing their benefits in coronary heart disease.
Gotto
A M
AM
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018579:Patient Selection
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors